We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Releases Biogeneric Guidelines; Approvals Expected
The European Medicines Agency (EMEA) has published five product-specific final industry guidelines for the development of biogenerics — a move that comes as European regulators are expected soon to approve their first generic biologic.